NCT03112447 is a NA clinical trial of absorbable cartilage nail in Fracture Arm, sponsored by Children's Hospital of Chongqing Medical University.

Who is sponsoring NCT03112447?

NCT03112447 is sponsored by Children's Hospital of Chongqing Medical University.

What drugs are being tested in NCT03112447?

Interventions in NCT03112447: absorbable cartilage nail, traditional Kirschner wires.

What condition does NCT03112447 study?

NCT03112447 studies Fracture Arm.

Is NCT03112447 still recruiting?

NCT03112447 is currently completed. Last updated 13 April 2017.

Last reviewed 2017-04-13 · How we verify

NCT03112447

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Medial Humeral Epicondyle Fractures in Children With Absorbable Cartilage Nails

Completed NA Last updated 13 April 2017

What this trial tests

NA trial testing absorbable cartilage nail in Fracture Arm in 32 participants. Completed in 1 August 2012.

Timeline

1 August 2007

Primary endpoint
1 August 2012

1 August 2012

Quick facts

Lead sponsor	Children's Hospital of Chongqing Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	32
Start date	1 August 2007
Primary completion	1 August 2012
Estimated completion	1 August 2012

Drugs / interventions tested

absorbable cartilage nail
traditional Kirschner wires

Conditions studied

Fracture Arm — all drugs for Fracture Arm →

Sponsor

Children's Hospital of Chongqing Medical University

Who can join

Adults 8 to 14, any sex, with Fracture Arm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare surgical outcomes from medial epicondyle fracture fixation with absorbable cartilage nails to those from traditional Kirschner wire fixation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fracture Arm

Currently open trials in the same condition.

NCT04299022 — Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care · recruiting

Other Children's Hospital of Chongqing Medical University trials

Trials by the same sponsor.

NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
NCT07472829 — Research on Speech Development Trajectories and Predictive Models in Children With Autism Spectrum Disorder · not yet recruiting
NCT05911893 — the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children · NA · recruiting
NCT06404294 — The External Diaphragm Pacemaker Assisted Extubation in Premature Infants With Invasive Mechanical Ventilation · NA · recruiting
NCT05768399 — The Role of Biomarkers in the Occurrence and Development of Asthma · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03112447 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Chongqing Medical University
Last refreshed: 13 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03112447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing